(RTTNews) - India-based Glenmark Pharmaceuticals Inc.'s USA subsidiary, Thursday announced the launch of Clindamycin Phosphate Foam, 1 percent for the treatment of acne. The company added that ...

LAVAL, QC / ACCESSWIRE / October 20, 2023 / Bausch Health Companies Inc. (NYSE:BHC) (TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food ...

The approval of Cabtreo was based on data from 2 placebo-controlled phase 3 studies. Cabtreo combines clindamycin phosphate, a lincosamide antibacterial, adapalene, a retinoid, and benzoyl peroxide, ...

Please provide your email address to receive an email when new articles are posted on . 52.7% of pediatric patients treated with the triple-combination gel vs. 24% of vehicle-treated patients achieved ...

December 1, 2006 — The US Food and Drug Administration (FDA) has approved clindamycin phosphate/tretinoin 1.2%/0.025% gel for the once-daily topical treatment of acne vulgaris in patients aged 12 ...

Cabtreo combines clindamycin phosphate, a lincosamide antibacterial, adapalene, a retinoid, and benzoyl peroxide, an oxidizing agent with bactericidal and keratolytic effects, into one topical gel.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The triple-combination ...

Step into your local drugstore and you’ll come across countless cleansers, serums, lotions and masks all promising the same thing: fewer acne breakouts and clearer, smoother skin. Unfortunately, not ...

Clindamycin is an antibiotic in the lincosamide class, active against gram positive bacteria and anaerobes. It binds to the large subunit (50S) of the bacterial ribosome and inhibits new ...